Eric Lenze, MD
Enriched profileHead of the Department of Psychiatry; Wallace and Lucille K. Renard Professor of Psychiatry · Washington University School of Medicine in St. Louis
Eric Lenze is Head of the Department of Psychiatry; Wallace and Lucille K. Renard Professor of Psychiatry at Washington University School of Medicine in St. Louis. OpenAlex indexes 546 publications with 20,832 citations (h-index 74); ClinicalTrials.gov lists 24 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Eric Lenze, MD, is Head of the Department of Psychiatry at Washington University School of Medicine in St. Louis. The public record shows 546 publications with 20,832 citations (h-index 74), centered on Depression (MDD), Schizophrenia. It also documents an investigator role on 24 registered clinical trials, industry payments reported by 4 companies, 12 NIH-funded awards (2008–2025).
- Most recent indexed publication: 2026 · medRxiv
- Top research focus: Depression (MDD)
- 24 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 24 registered studies on ClinicalTrials.gov. The most recent:
- INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
Sponsor: Washington University School of Medicine
- Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
Sponsor: Washington University School of Medicine
Industry payments
Updated 27 Aug 2026
4 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20231 payment
- ITI, Inc.Program year20231 payment
- Merck Sharp & Dohme LLCProgram year202210 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.4%Benzodiazepine32.1%Clonazepam34%Alprazolam32%Lorazepam21%Diazepam9%Temazepam3%Part D<11 patientsSNRI17.7%Duloxetine Hcl47%Venlafaxine Hcl Er32%Desvenlafaxine Succinate Er15%Venlafaxine Hcl5%Part D<11 patientsCardiovascular
3.6%Statin2.5%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker1.1%Amlodipine Besylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
12 NIH research awards on record, funded 2008–2025 per NIH RePORTER. The latest:
- Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Trial
Washington University
FY2025$699,647U01MH128483 - Resilience and brain health of older adults during the COVID-19 pandemic
Washington University
FY2024$1,803,334R01AG072694
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- High-Frequency, At-Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID-19 Treatment.
Clinical and translational science
Clinical Trial2025 - CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression.
Clinical pharmacology and therapeutics
Article2024 - The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.
Open forum infectious diseases
Article2023 - Mindfulness Training for Depressed Older Adults Using Smartphone Technology: Protocol for a Fully Remote Precision Clinical Trial.
JMIR research protocols
Article2022
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/eric-lenze-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Eric-J-Lenze-38924691
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - X / Twitter
x.com/EricLenze2
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- Other
medicine.washu.edu/news/lenze-named-head-of-department-of-psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.washu.edu ↗ - X / Twitter
X (Twitter): @EricLenze2
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Geriatric Psychiatry Fellowship
University of Pittsburgh School of Medicine, Late-Life Mood Disorder Center
1999verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- Board Certified
Geriatric Psychiatry (American Board of Psychiatry and Neurology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- Director
Division of Geriatric Psychiatry, Washington University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗ - Director
Mobile Health Research Core, Institute of Clinical and Translational Sciences, Washington University in St. Louis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
Secondary affiliations
appointments beyond the home institution- Professor of Anesthesiology
Washington University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗ - Faculty affiliate
Institute for Public Health, Washington University in St. Louis
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →publichealth.wustl.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cbsnews.com ↗
- Podcast guest: "Fluvoxamine for Early Treatment of COVID-19: The STOP COVID Clinical Trials"
Rethinking Clinical Trials
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rethinkingclinicaltrials.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →trialsitenews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramaswamy Govindan, MD
Washington University School of Medicine in St. Louis
Marin Kollef, MD
Washington University School of Medicine in St. Louis
Mark Huffman, MD
Washington University School of Medicine in St. Louis
Brad Kahl, MD
Washington University School of Medicine in St. Louis